NLRP3 and chronic kidney disease: NLRP3, IL-1β, and IL-18 are significantly upregulated in chronic kidney disease patients undergoing hemodialysis treatment, indicating that the NLRP3 inflammasome may be activated in and contribute to chronic inflammation in CKD [46].